Dapagliflozin use-result surveillance results from the Korean drug label.

<p>AE, adverse event; ADR, adverse drug reaction; COPD, Chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; GI, gastrointestinal; NOS, not otherwise specified; PAOD, Peripheral arteriosclerotic occlusive disease; SGOT, serum glutamic oxaloacetic; SGPT, serum glutamic pyruvate transaminase; WHO-ART, World Health Organization adverse reaction terminology.</p> <p>(DOCX)</p>